A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease-Reference-Cited by-同舟云学术

A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease

Published:2006-08 Issue:4 Volume:13 Page:515-522
ISSN:1741-8267
Container-title:European Journal of Cardiovascular Prevention & Rehabilitation
language:en
Short-container-title:European Journal of Cardiovascular Prevention & Rehabilitation

Author:

Liew Danny¹,Lim Stephen S.²,Bertram Melanie²,McNeil John J.¹,Vos Theo²

Affiliation:

1. NHMRC Centre for Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Melbourne, Victoria

2. Centre for Burden of Disease and Cost-Effectiveness, School of Population Health, University of Queensland, Herston, Queensland, Australia.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1097/01.hjr.0000224488.03221.97

Reference30 articles.

1. Epidemiological modelling (including economic modelling) and its role in preventive drug therapy

2. Global Burden of Cardiovascular Diseases

3. Global Burden of Cardiovascular Diseases

4. Getting research findings into practice: Decision analysis and the implementation of research findings

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chapter 13: Cost-Effectiveness Analysis, Cost-Utility Analysis, and Cost-Benefit Analysis;Understanding Health Outcomes and Pharmacoeconomics;2017-04

2. Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions;Population Health Metrics;2016-05-04

3. Impact of Health Insurance Expansions on Nonelderly Adults With Hypertension;Preventing Chronic Disease;2015-07-02

4. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia;European Journal of Preventive Cardiology;2013-11-26

5. Overview of pharmacoeconomic modelling methods;British Journal of Clinical Pharmacology;2013-03-15